Moore Capital Management, LP Bluebird Bio, Inc. Transaction History

Moore Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $275,000 - $379,200	-10,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $271,200 - $459,700	10,000 New	10,000 $610,000
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $1.95 Million - $2.78 Million	-18,400 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $1.5 Million - $2.4 Million	18,400	18,400 $3.28 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.